Sai Life Sciences is launching its IPO on December 11, offering shares priced between ₹522-549 each. The sale includes ₹950 crore in fresh shares and ₹2,092.62 crore through an offer for sale by promoters and existing shareholders. Proceeds will fund debt repayment and corporate purposes. The IPO closes on December 13, and shares will debut on December 18. Retail investors have 35% reserved, while QIBs get 50%. Sai Life Sciences serves global pharmaceutical clients and reported ₹693.35 crore revenue for the first half of FY24.
Posted inIPO News Market News